While new medical discoveries and innovations are in the news every day, doctors struggle daily with using information and techniques available right now while carefully adopting new concepts and treatments.
Vice President Joe Biden will bring together scientists, oncologists, donors and patients for a national conference on cancer research in Washington, the White House said Tuesday.
Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars.
Europe's main drug regulator has lifted a 7-year-old warning about possible suicidal risks from Chantix, Pfizer's smoking-cessation pill.
Visceral leishmaniasis is a disease which blights the developing world with 200,000 to 400,000 new cases and 48,000 deaths annually.
In terms of the potential competition CCX168 may face in the AAV market, GlobalData expects that the drug will hold an advantage over several competitors due to attractive pricing.
Physicians are prescribing antidepressants for many reasons that range beyond a depression diagnosis. So says a recent study published in the Journal of the American Medical Association.
The erroneous tests could have led to thousands of misdirected health-care decisions over those two years.
The drug is a topical prescription for treating persistent facial erythema.
Viruses attack cells and commandeer their machinery in a complex and carefully orchestrated invasion.
This is the latest round in a legal battle between the Belgian pharmaceutical company and generic rivals.
There are lessons to be learned from venoms.
Understanding how this works has potential for therapeutic purposes.
Joseph Papa shed light on the potential strategy for reducing the drug maker's debt load.
Combination approaches have the potential to generate twice as many sales in the recurrent RCC market.